Skip to main content
Top
Published in: Journal of General Internal Medicine 1/2008

Open Access 01-01-2008 | Original Article

Programmable Infusion Pumps in ICUs: An Analysis of Corresponding Adverse Drug Events

Authors: Teryl K. Nuckols, MD, MSHS, Anthony G. Bower, PhD, Susan M. Paddock, PhD, Lee H. Hilborne, MD, MPH, Peggy Wallace, RN, MSN, Jeffrey M. Rothschild, MD, MPH, Anne Griffin, RN, MPH, Rollin J. Fairbanks, MD, MS, Beverly Carlson, MS, RN, CNS, Robert J. Panzer, MD, Robert H. Brook, ScD, MD

Published in: Journal of General Internal Medicine | Special Issue 1/2008

Login to get access

Abstract

Background

Patients in intensive care units (ICUs) frequently experience adverse drug events involving intravenous medications (IV-ADEs), which are often preventable.

Objectives

To determine how frequently preventable IV-ADEs in ICUs match the safety features of a programmable infusion pump with safety software (“smart pump”) and to suggest potential improvements in smart-pump design.

Design

Using retrospective medical-record review, we examined preventable IV-ADEs in ICUs before and after 2 hospitals replaced conventional pumps with smart pumps. The smart pumps alerted users when programmed to deliver duplicate infusions or continuous-infusion doses outside hospital-defined ranges.

Participants

4,604 critically ill adults at 1 academic and 1 nonacademic hospital.

Measurements

Preventable IV-ADEs matching smart-pump features and errors involved in preventable IV-ADEs.

Results

Of 100 preventable IV-ADEs identified, 4 involved errors matching smart-pump features. Two occurred before and 2 after smart-pump implementation. Overall, 29% of preventable IV-ADEs involved overdoses; 37%, failures to monitor for potential problems; and 45%, failures to intervene when problems appeared. Error descriptions suggested that expanding smart pumps’ capabilities might enable them to prevent more IV-ADEs.

Conclusion

The smart pumps we evaluated are unlikely to reduce preventable IV-ADEs in ICUs because they address only 4% of them. Expanding smart-pump capabilities might prevent more IV-ADEs.
Literature
1.
go back to reference Rothschild JM, Landrigan CP, Cronin JW, et al. The critical care safety study: The incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med. 2005;33(8):1694–700.PubMedCrossRef Rothschild JM, Landrigan CP, Cronin JW, et al. The critical care safety study: The incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med. 2005;33(8):1694–700.PubMedCrossRef
2.
go back to reference Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274(1):29–34.PubMedCrossRef Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274(1):29–34.PubMedCrossRef
3.
go back to reference Apkon M, Leonard J, Probst L, DeLizio L, Vitale R. Design of a safer approach to intravenous drug infusions: failure mode effects analysis. Qual Saf Health Care. 2004;13(4):265–71.PubMedCrossRef Apkon M, Leonard J, Probst L, DeLizio L, Vitale R. Design of a safer approach to intravenous drug infusions: failure mode effects analysis. Qual Saf Health Care. 2004;13(4):265–71.PubMedCrossRef
5.
go back to reference Fields M, Peterman J. Intravenous medication safety system averts high-risk medication errors and provides actionable data. Nurs Adm Q. 2005;29(1):78–87.PubMed Fields M, Peterman J. Intravenous medication safety system averts high-risk medication errors and provides actionable data. Nurs Adm Q. 2005;29(1):78–87.PubMed
6.
go back to reference Hatcher I, Sullivan M, Hutchinson J, Thurman S, Gaffney FA. An intravenous medication safety system: preventing high-risk medication errors at the point of care. J Nurs Adm. 2004;34(10):437–9.PubMedCrossRef Hatcher I, Sullivan M, Hutchinson J, Thurman S, Gaffney FA. An intravenous medication safety system: preventing high-risk medication errors at the point of care. J Nurs Adm. 2004;34(10):437–9.PubMedCrossRef
7.
go back to reference Malashock CM, Shull SS, Gould DA. Effect of smart infusion pumps on medication errors related to infusion device programming. Hosp Pharm. 2004;39(5):460–9. Malashock CM, Shull SS, Gould DA. Effect of smart infusion pumps on medication errors related to infusion device programming. Hosp Pharm. 2004;39(5):460–9.
8.
go back to reference Rothschild JM, Keohane CA, Cook EF, et al. A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med. 2005;33(3):533–40.PubMedCrossRef Rothschild JM, Keohane CA, Cook EF, et al. A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med. 2005;33(3):533–40.PubMedCrossRef
9.
go back to reference Rozich JD, Haraden CR, Resar RK. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care. 2003;12(3):194–200.PubMedCrossRef Rozich JD, Haraden CR, Resar RK. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care. 2003;12(3):194–200.PubMedCrossRef
10.
go back to reference Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.PubMedCrossRef Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.PubMedCrossRef
11.
go back to reference Dubois RW, Brook RH. Preventable deaths: who, how often, and why? Ann Intern Med. 1988;109(7):582–9.PubMed Dubois RW, Brook RH. Preventable deaths: who, how often, and why? Ann Intern Med. 1988;109(7):582–9.PubMed
12.
go back to reference Landis RJ, Koch GG. A one-way components of variance model for categorical data. Biometrics. 1977;33(4):671–9.CrossRef Landis RJ, Koch GG. A one-way components of variance model for categorical data. Biometrics. 1977;33(4):671–9.CrossRef
13.
go back to reference Husch M, Sullivan C, Rooney D, et al. Insights from the sharp end of intravenous medication errors: implications for infusion pump technology. Qual Saf Health Care. 2005;14(2):80–6.PubMedCrossRef Husch M, Sullivan C, Rooney D, et al. Insights from the sharp end of intravenous medication errors: implications for infusion pump technology. Qual Saf Health Care. 2005;14(2):80–6.PubMedCrossRef
14.
go back to reference Heinemann L, Anderson JH Jr. Measurement of insulin absorption and insulin action. Diabetes Technol Ther. 2004;6(5):698–718.PubMedCrossRef Heinemann L, Anderson JH Jr. Measurement of insulin absorption and insulin action. Diabetes Technol Ther. 2004;6(5):698–718.PubMedCrossRef
15.
go back to reference Gentilini A, Schaniel C, Morari M, Bieniok C, Wymann R, Schnider T. A new paradigm for the closed-loop intraoperative administration of analgesics in humans. IEEE Trans Biomed Eng. 2002;49(4):289–99.PubMedCrossRef Gentilini A, Schaniel C, Morari M, Bieniok C, Wymann R, Schnider T. A new paradigm for the closed-loop intraoperative administration of analgesics in humans. IEEE Trans Biomed Eng. 2002;49(4):289–99.PubMedCrossRef
16.
go back to reference Poon EG, Blumenthal D, Jaggi T, Honour MM, Bates DW, Kaushal R. Overcoming barriers to adopting and implementing computerized physician order entry systems in U.S. hospitals. Health Aff (Millwood). 2004;23(4):184–90.CrossRef Poon EG, Blumenthal D, Jaggi T, Honour MM, Bates DW, Kaushal R. Overcoming barriers to adopting and implementing computerized physician order entry systems in U.S. hospitals. Health Aff (Millwood). 2004;23(4):184–90.CrossRef
17.
go back to reference Wickens CD, Lee J, Liu Y, Becker SG. An Introduction to Human Factors Engineering. Saddle, NJ: Pearson/Prentice Hall; 2004:426. Wickens CD, Lee J, Liu Y, Becker SG. An Introduction to Human Factors Engineering. Saddle, NJ: Pearson/Prentice Hall; 2004:426.
18.
go back to reference Koppel R, Metlay JP, Cohen A, et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA. 2005;293(10):1197–203.PubMedCrossRef Koppel R, Metlay JP, Cohen A, et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA. 2005;293(10):1197–203.PubMedCrossRef
19.
go back to reference Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care. 2004;13(4):306–14.PubMedCrossRef Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care. 2004;13(4):306–14.PubMedCrossRef
Metadata
Title
Programmable Infusion Pumps in ICUs: An Analysis of Corresponding Adverse Drug Events
Authors
Teryl K. Nuckols, MD, MSHS
Anthony G. Bower, PhD
Susan M. Paddock, PhD
Lee H. Hilborne, MD, MPH
Peggy Wallace, RN, MSN
Jeffrey M. Rothschild, MD, MPH
Anne Griffin, RN, MPH
Rollin J. Fairbanks, MD, MS
Beverly Carlson, MS, RN, CNS
Robert J. Panzer, MD
Robert H. Brook, ScD, MD
Publication date
01-01-2008
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue Special Issue 1/2008
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0414-y

Other articles of this Special Issue 1/2008

Journal of General Internal Medicine 1/2008 Go to the issue

Introduction

Introduction

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.